510(k) · Cleared
ClearedPremier Platinum Hpsa Plus, Models 601396, 601480
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Meridian Bioscience, Inc. · LYR Helicobacter Pylori
Cleared on Mar 10, 2006 as substantially equivalent to K980076 (Meridian Diagnostics, Inc., 1998) and 1 other predicate after a 99-day review. Its family tree reaches back 1 generation to 1998. 6 later devices descend from it.
- Decided
- Mar 10, 2006
- Review
- 99 days
- Class
- Class I
- Product code
- LYR
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 1 generation to K980076 (1998). 2 ancestors in all. 6 later devices descend from it, 3 citing it directly.
- Root · 1 generation backK980076 Premier Platinum HpsaMeridian Diagnostics, Inc. · 1998
- This deviceK053335 Premier Platinum Hpsa Plus, Models 601396, 601480Meridian Bioscience, Inc. · 2006
- Descendant · cites it directly · 3 of its ownK182559 PREMIER Platinum HpSA PLUSMeridian Bioscience, Inc. · 2018
- Descendant · 2 generations on · 0 of its ownK232892 Hp Detect™ Stool Antigen ELISABiomerica, Inc. · 2023
- Descendant · 2 generations on · 0 of its ownK230901 Premier HpSA Flex (619096)Meridian Bioscience, Inc. · 2023
- Descendant · 2 generations on · 0 of its ownK192817 Curian HpSA, Curian AnalyzerMeridian Bioscience, Inc. · 2020
- Descendant · cites it directly · 0 of its ownK181464 LIAISON Helicobacter Antigen, LIAISON Helicobacter Antigen Control SetDiaSorin, Inc. · 2018
Showing 5 of 6 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 6 · See all- K182559PREMIER Platinum HpSA PLUSMeridian Bioscience, Inc. · 2018 · cites it directly3descendants
- K232892Hp Detect™ Stool Antigen ELISABiomerica, Inc. · 2023 · 2 generations on0descendants
- K230901Premier HpSA Flex (619096)Meridian Bioscience, Inc. · 2023 · 2 generations on0descendants
- K192817Curian HpSA, Curian AnalyzerMeridian Bioscience, Inc. · 2020 · 2 generations on0descendants
- K181464LIAISON Helicobacter Antigen, LIAISON Helicobacter Antigen Control SetDiaSorin, Inc. · 2018 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K980076 | Premier Platinum Hpsa | Meridian Diagnostics, Inc. | 1998 | — |
| 0 (this device) | K053335 | Premier Platinum Hpsa Plus, Models 601396, 601480 | Meridian Bioscience, Inc. | 2006 | — |
| +1 | K182559 | PREMIER Platinum HpSA PLUS | Meridian Bioscience, Inc. | 2018 | — |
| +2 | K232892 | Hp Detect™ Stool Antigen ELISA | Biomerica, Inc. | 2023 | — |
| +2 | K230901 | Premier HpSA Flex (619096) | Meridian Bioscience, Inc. | 2023 | — |
| +2 | K192817 | Curian HpSA, Curian Analyzer | Meridian Bioscience, Inc. | 2020 | — |
| +1 | K181464 | LIAISON Helicobacter Antigen, LIAISON Helicobacter Antigen Control Set | DiaSorin, Inc. | 2018 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1998 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2018 | 3 | 0 |
| 2020 | 1 | 0 |
| 2023 | 2 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LYR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LYR device
- #1 K232892 Hp Detect™ Stool Antigen ELISAscore 7.1 · 3 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K980076 | Premier Platinum HpsaSummary page 1…YR, CFR section 866.3110 Predicate device to which this device is being compared: Premier Platinum HpSA (Meridian Bioscience, Inc., Cincinnati, OH) (K980076, K983255) Device description: Premier Platinum HpSA PLUS is an in vitro diagnostic, microwell-based, enzyme- linked immunoassay f… | 1998 |
| * | K983255 | Modification to: Premier Platinum HpsaSummary page 1…ection 866.3110 Predicate device to which this device is being compared: Premier Platinum HpSA (Meridian Bioscience, Inc., Cincinnati, OH) (K980076, K983255) Device description: Premier Platinum HpSA PLUS is an in vitro diagnostic, microwell-based, enzyme- linked immunoassay for the de… | 1998 |
What descends from it? (6)
3 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- 1 of the 2 ancestors has a recall of any class.
- Of its descendants, K182559 (Meridian Bioscience, Inc., 2018) has gone furthest, with 3 descendants of its own.
How does its category compare?
All LYR devicesLYR Helicobacter Pylori: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · LYR
2in 2023
2026 to Oct 25, outlined.
Median 510(k) review, days · LYR
86in 2018
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LYR
2in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LYR
2in 2023
MAUDE reports naming product code LYR, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 2 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 1 | 1 |
| 2011 | 0 | — | 0 | 2 |
| 2012 | 2 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 2 | — | 0 | 2 |
| 2016 | 2 | — | 0 | 4 |
| 2017 | 0 | — | 0 | 1 |
| 2018 | 4 | 86 | 0 | 0 |
| 2019 | 1 | — | 0 | 0 |
| 2020 | 1 | — | 0 | 4 |
| 2021 | 0 | — | 0 | 1 |
| 2022 | 0 | — | 3 | 0 |
| 2023 | 2 | — | 1 | 2 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 2 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Premier Platinum HpSA PLUS enzyme immunoassay (EIA) is an in vitro qualitative procedure for
the detection of Helicobacter pylor antigens in human stool. Test results are intended to aid in the
diagnosis of H.pylori infection and to monitor response during and post-therapy in patients. Accepted
medical practice recommends that testing by any current method, to confirm eradication, be done at
least four weeks following completion of therapy.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K053335 · printed Nov 4, 2026
Cite this page
510(k) Report. “K053335: Premier Platinum Hpsa Plus, Models 601396, 601480.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K053335
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026